KINNATE BIOPHARMA INC (KNTE)
US49705R1059 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.65M | -116.27M | -89.76M | -35.76M | -11.97M | |||
| Depreciation Amortization | 799.00K | 600.00K | 120.00K | 80.00K | N/A | |||
| Change In Working Capital | -3.70M | 6.37M | 1.62M | 3.01M | 1.40M | |||
| Other non cash items | 15.51M | 20.26M | 16.95M | 2.48M | 40.00K | |||
| OPERATING CASH FLOW | -100.04M | -89.03M | -71.07M | -30.18M | -10.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -2.72M | -770.00K | -300.00K | N/A | |||
| Other Investing Activity | 109.87M | -4.11M | -179.81M | -31.41M | N/A | |||
| INVESTING CASH FLOW | 109.87M | -6.83M | -180.57M | -31.71M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.32M | 1.57M | 1.62M | 350.92M | 5.78M | |||
| Other Financing Activity | -9.13M | -410.00K | 34.62M | -20.00K | 74.20M | |||
| FINANCING CASH FLOW | -7.81M | 1.16M | 36.24M | 350.90M | 79.98M | |||
| Exchange Rate Effect | -6.00K | 0.00 | N/A | N/A | N/A | |||
| CHANGE IN CASH | 2.01M | -94.70M | -215.40M | 289.01M | 69.45M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -100.04M | -89.03M | -71.07M | -30.18M | -10.53M | |||
| Capital Expenditure | 0.00 | -2.72M | -770.00K | -300.00K | N/A | |||
| FREE CASH FLOW | -100.04M | -91.75M | -71.84M | -30.48M | -10.53M | |||
All data in USD